Enhances patient engagement and care coordination through personalized insights and workflow automation.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
AppOrchid is a digital health technology company that provides an AI-driven platform to improve patient engagement, clinical outcomes, and care coordination. Its software integrates with existing electronic health records to deliver personalized health insights, automate workflows, and support remote patient monitoring. The platform aims to make healthcare more proactive and data-driven, helping providers and patients make informed decisions.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
AppOrchid Management Team
AppOrchid Valuations & Financials
View real-time NPM data on AppOrchid stock including daily AppOrchid stock price estimates, valuation history, and historical share price information. Access AppOrchid financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track AppOrchid pricing across six independent market signals. Looking for private company due diligence data sources on AppOrchid? Get in touch to learn more.
Similar Companies
like AppOrchid
Persist AI
Healthcare & Life Sciences
Develops long-acting injectable drug formulations through screening, testing, and scale-up to solve clearance and stability issues.
Potrero
Healthcare & Life Sciences
Develops technology that monitors patient data in real time to detect complications early and support clinical decision-making.
Exthymic
Healthcare & Life Sciences
Develops decentralized cell therapy manufacturing solutions to enhance accessibility and scalability of autologous treatments.
ShiraTronics
Healthcare & Life Sciences
Develops innovative neuromodulation technology for migraine therapy, focusing on clinical testing of implantable medical devices.
StimAire
Healthcare & Life Sciences
Develops non-surgical neural stimulation technology using wearables and injectables to treat medical conditions without invasive procedures.
Iodine Software
Healthcare & Life Sciences
AI-powered software platform optimizes healthcare revenue cycle management through clinical documentation and reimbursement solutions.
Lover
Healthcare & Life Sciences
Provides personalized sexual health guidance and interactive tools to support intimacy and experience improvement.
Heartbeat Health
Healthcare & Life Sciences
Deliver cardiology that reaches patients via diagnostics, virtual care, and outcome-based coordination to reduce risk and improve heart health.
restor3d
Healthcare & Life Sciences
Creating implants that adapt to patient anatomy through AI-driven three dimensional printing for more precise and effective surgical outcomes.
FAQ
We have answers
AppOrchid stock does not trade on public stock exchanges. AppOrchid stock is considered a private security and you need to be an accredited investor to trade shares. To invest in AppOrchid stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
AppOrchid Stock does not trade on public stock exchanges. In order to sell AppOrchid shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
AppOrchid does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view AppOrchid share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for AppOrchid stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell AppOrchid stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in AppOrchid stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
AppOrchid is a private company and has not had an IPO. There is currently no AppOrchid IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to AppOrchid IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
